We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Critical Report Unlikely to Change FDA Postmarket Policies
Critical Report Unlikely to Change FDA Postmarket Policies
July 14, 2006
The FDA seems unlikely to heed a recent HHS Office of
Inspector General (OIG) report on postmarketing reviews, opposing the report’s call for substantive changes to agency policy.